| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.32 | 0.03 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.45 | 0.03 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.29 | 0.03 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.12 | 0.03 |